Skip to content

Clinical trials

Multiple Sclerosis, Relapsing-Remitting trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Country / region: Hungary Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20051
20061
20071
20081
20094
20105
20113
20121
20135
20142
20161
20172
20192
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated9
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen12
Bayer4
Hoffmann-La Roche3
Novartis Pharmaceuticals3
GeNeuro SA2
Tanabe Pharma Corporation2
EMD Serono1
Eli Lilly and Company1
Grifols Therapeutics LLC1
Nuron Biotech Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting33
Multiple Sclerosis17
Demyelinating Diseases1
Diffuse Cerebral Sclerosis of Schilder1
Neuromyelitis Optica1
Recurrence1
Sclerosis1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.